Registration Frequencies

Weekly updated frequencies of observation starts at registration by medication are shown.

Fig 1) Patient numbers by biologic treatment at inclusion
Last update: 03. November | total n= 28,071

Fig 1) Patient numbers by biologic treatment at inclusion

 

Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion
Last update: 03. November | total n= 28,071
Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion

 

Show table for Fig. 1/2Hide table

Inclusion Treatment Patient Number of that with similar agents (e.g. Biosimilars)
Adalimumab 1102 1702
Bimekizumab 538 0
Brodalumab 612 0
Certolizumab 256 0
Efalizumab 35 0
Etanercept 312 72
Golimumab 25 0
Guselkumab 2349 0
Infliximab 102 1
Ixekizumab 1182 0
Risankizumab 2434 0
Secukinumab 2321 0
Tildrakizumab 2038 0
Ustekinumab 785 82
Apremilast 816 0
Ciclosporin 402 0
Deucravacitinib 337 0
Fumaric acid esters 2694 0
Dimethyl fumarate 3583 0
Methotrexate 3924 0
Tofacitinib 2 0
Upadacitinib 9 0
other systemics 356 0

 

Fig. 3) Rate of patients by medication class at inclusion
Last update: 03. November | total n= 28,071

 

Fig. 4) Rate of patients by type of registry site
Last update: 03. November | total n= 28,071

 

Fig. 5) Registered PsoBest centers
Last update: 27. October| n= 1,215 | updated monthly